T-helper 1 (Th1) cells are believed to be the major producer of the type 1
cytokine interferon-gamma (IFN-gamma) in cell-mediated immunity against int
racellular infection. We have investigated the ability of macrophages to re
lease type 1 cytokines and their regulatory mechanisms using both in vivo a
nd in vitro models of pulmonary mycobacterial infection. During pulmonary i
nfection by live Mycobacterium bovis bacilli Calmette-Guerin (BCG) in wild-
type mice, lung macrophages released interleukin-12 (IL-12), IFN-gamma, and
tumor necrosis factor-alpha (TNF-alpha), and expressed surface activation
markers. However, macrophages in infected IL-12(-/-) mice released TNF-alph
a but not IFN-gamma and lacked surface activation makers. In freshly isolat
ed lung macrophages from naive IL-2(-/-) mice, mycobacteria alone released
TNF-alpha but not IFN-gamma, whereas exogenously added IL-12 alone released
a minimum of IFN-gamma. However, these macrophages released large quantiti
es of IFN-gamma upon stimulation with both mycobacteria and IL-12. In contr
ast, mycobacteria and exogenous IFN-gamma released only a minimum of endoge
nous IFN-gamma. Endogenous IL-18 (IFN-gamma-inducing factor) played little
role in IFN-gamma responses by macrophages stimulated by mycobacteria and I
L-12. Our data reveal that macrophages are a significant source of type 1 c
ytokines during mycobacterial infection and that both IL-12 and intracellul
ar pathogens are required for the release of IFN-gamma but neat TNF-alpha.
These findings suggest that macrophages regulate cell-mediated immunity by
releasing not only IL-12 and TNF-alpha but also IFN-gamma and that full act
ivation of IFN-gamma response in macrophages is tightly regulated.